Sernova Biotherapeutics (FRA:PSH0) Change In Payables And Accrued Expense : €2.20 Mil (TTM As of Apr. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics Change In Payables And Accrued Expense?

Sernova Biotherapeutics's Change In Payables And Accrued Expense for the quarter that ended in Apr. 2025 was €-0.42 Mil. It means Sernova Biotherapeutics's Accounts Payable & Accrued Expense declined by €0.42 Mil from Jan. 2025 to Apr. 2025 .

Sernova Biotherapeutics's Change In Payables And Accrued Expense for the fiscal year that ended in Oct. 2024 was €7.07 Mil. It means Sernova Biotherapeutics's Accounts Payable & Accrued Expense increased by €7.07 Mil from Oct. 2023 to Oct. 2024 .

Sernova Biotherapeutics Change In Payables And Accrued Expense Historical Data

The historical data trend for Sernova Biotherapeutics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Change In Payables And Accrued Expense Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.14

0.32

2.45

3.28

7.07

Sernova Biotherapeutics Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															1.74	1.85	0.43	0.35	-0.42

Sernova Biotherapeutics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.20 Mil.

Sernova Biotherapeutics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany SVA:Canada

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines